Get started
Author

Sarah S. Burns

Obesity-induced inflammation exacerbates clonal hematopoiesis
2023 · Santhosh Kumar Pasupuleti, Baskar Ramdas, et al. · Journal of Clinical Investigation · 119
PDF
AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas
2011 · M. L. Bush, J. Oblinger, et al. · Neuro-Oncology · 78
PDF
Histone Deacetylase Inhibitor AR-42 Differentially Affects Cell-cycle Transit in Meningeal and Meningioma Cells, Potently Inhibiting NF2 -Deficient Meningioma Growth
2012 · Sarah S. Burns, Elena M. Akhmametyeva, et al. · Cancer Research · 56
Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK
2021 · Long-Sheng Chang, Janet L. Oblinger, et al. · PLoS ONE · 54
PDF
Early phase clinical studies of AR ‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas
2021 · D. Bradley Welling, Katharine A. Collier, et al. · Laryngoscope Investigative Otolaryngology · 37
PDF
Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells
2017 · Marisa A. Fuse, Stephani Klingeman Plati, et al. · Molecular Cancer Therapeutics · 36
Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas
2016 · Janet L. Oblinger, Sarah S. Burns, et al. · Neuro-Oncology · 36
Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2
2018 · Robert Allaway, Steve P. Angus, et al. · PLoS ONE · 35
PDF
Il-1r1 drives leukemogenesis induced by Tet2 loss
2022 · Sarah S. Burns, Ramesh Kumar, et al. · Leukemia · 32
PDF
Targeting SHP2 phosphatase in hematological malignancies
2022 · Rahul Kanumuri, Santhosh Kumar Pasupuleti, et al. · Expert Opinion on Therapeutic Targets · 31
Fate of Hematopoiesis During Aging. What Do We Really Know, and What are its Implications?
2020 · Hal E. Broxmeyer, Yan Liu, et al. · Stem Cell Reviews and Reports · 30
PDF
Natural Compounds as Potential Treatments of NF2-Deficient Schwannoma and Meningioma
2013 · Samuel A. Spear, Sarah S. Burns, et al. · Otology & Neurotology · 29
Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation
2017 · Janet L. Oblinger, Sarah S. Burns, et al. · Experimental Neurology · 26
Treatment of Vestibular Schwannoma Cells With ErbB Inhibitors
2012 · Matthew L. Bush, Sarah S. Burns, et al. · Otology & Neurotology · 23
Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other Sarcomas
2019 · Long-Sheng Chang, Janet L. Oblinger, et al. · Molecular Cancer Therapeutics · 22
Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia
2020 · Sarah S. Burns, Reuben Kapur · Stem Cell Reports · 17
Driver Mutations in Leukemia Promote Disease Pathogenesis through a Combination of Cell-Autonomous and Niche Modulation
2020 · Baskar Ramdas, Raghuveer Singh Mali, et al. · Stem Cell Reports · 14
PDF
Generation of Noninvasive, Quantifiable, Orthotopic Animal Models for NF2-Associated Schwannoma and Meningioma
2016 · Sarah S. Burns, Long-Sheng Chang · Methods in molecular biology · 12
Obesity-Induced Inflammation Co-Operates with Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutants to Promote Leukemia Development and Cardiovascular Disease
2021 · Santhosh Kumar Pasupuleti, Baskar Ramdas, et al. · Blood · 8
Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate Potential
2020 · Sarah S. Burns, Reuben Kapur · Stem Cell Reports · 8
PDF
Turning the clock forward: Inflammation accelerates the aging of hematopoietic stem cells
2022 · Sarah S. Burns, Reuben Kapur · Cell stem cell · 6
Evolution and Origin of HRS, a Protein Interacting with Merlin, theNeurofibromatosis 2Gene Product
2009 · Leonid V. Omelyanchuk, Julia A. Pertseva, et al. · Gene Regulation and Systems Biology · 3
PDF
Combining Brigatinib with mTOR Inhibition to Effectively Treat NF2-SWN–Associated and Sporadic NF2 -Deficient Meningiomas
2025 · Long-Sheng Chang, Janet L. Oblinger, et al. · Cancer Research Communications · 2
PDF
Ref-1 drives ulcerative colitis induced systemic defects in hematopoietic cells
2026 · Ramesh Kumar, Rahul Kanumuri, et al. · Communications Biology · 1
PDF
Figure 5 from Combining Brigatinib with mTOR Inhibition to Effectively Treat NF2-SWN–Associated and Sporadic NF2-Deficient Meningiomas
2026 · Long-Sheng Chang, Janet L. Oblinger, et al.
Works count: 67
Citation count: 714
H-index: 16
I10-index: 18
Year
Topic
Type